Nancy D. Ebelt
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
-
- Immunotherapy and Immune Responses
- Immune cells in cancer
Papers in
- Oncology 13
- Cancer-related Molecular Pathways 4
- Cancer Cells and Metastasis 4
- Pancreatic and Hepatic Oncology Research 4
- Cancer Immunotherapy and Biomarkers 2
-
- Melanoma and MAPK Pathways 6
- DNA Repair Mechanisms 2
- Co-authors
- Edwin R. Manuel (12 shared papers)Monica Marzagalli (2 shared papers)Carla L. Van Den Berg (6 shared papers)M. A. Cantrell (1 shared paper)Travis H. Stracker (1 shared paper)Blerta Xhemalçe (1 shared paper)Kyle M. Miller (1 shared paper)Kevin N. Dalby (5 shared papers)
- Journals
- Cancers (3 papers)Oncotarget (3 papers)Nature Communications (2 papers)Cancer Research (2 papers)Cellular and Molecular Bioengineering (1 paper)
- Partner nations
- United StatesEgyptItaly
In The Last Decade
Nancy D. Ebelt
22 papers receiving 785 citations
Peers
Comparison fields: 5 of 84
- Oncology 293
- Immunology 193
- Biotechnology 61
- Immunology and Allergy 31
- Cell Biology 87
Countries citing papers authored by Nancy D. Ebelt
This map shows the geographic impact of Nancy D. Ebelt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy D. Ebelt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy D. Ebelt more than expected).
Fields of papers citing papers by Nancy D. Ebelt
This network shows the impact of papers produced by Nancy D. Ebelt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy D. Ebelt. The network helps show where Nancy D. Ebelt may publish in the future.
Co-authors
The 25 scholars most cited alongside Nancy D. Ebelt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 273 | |
| 2 | 2020 | 66 | |
| 3 | 2015 | 62 | |
| 4 | 2013 | 56 | |
| 5 | 2016 | 51 | |
| 6 | 2019 | 47 | |
| 7 | 2010 | 40 | |
| 8 | 2017 | 30 | |
| 9 | 2017 | 23 | |
| 10 | 2009 | 22 | |
| 11 | 2021 | 21 | |
| 12 | 2019 | 21 | |
| 13 | 2020 | 20 | |
| 14 | 2020 | 20 | |
| 15 | 2020 | 18 | |
| 16 | 2015 | 8 | |
| 17 | 2017 | 6 | |
| 18 | 2022 | 6 | |
| 19 | 2024 | 4 | |
| 20 | 2022 | 2 |
About Nancy D. Ebelt
Nancy D. Ebelt is a scholar working on Oncology, Molecular Biology, Biotechnology, Immunology and Pathology and Forensic Medicine, having authored 23 papers that have together received 798 indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (6 papers), Cancer Research and Treatments (5 papers), Cancer-related Molecular Pathways (4 papers), Cancer Cells and Metastasis (4 papers), Pancreatic and Hepatic Oncology Research (4 papers), Immunotherapy and Immune Responses (3 papers), DNA Repair Mechanisms (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Oncology (293 citations), Immunology (193 citations), Biotechnology (61 citations), Immunology and Allergy (31 citations) and Cell Biology (87 citations). Nancy D. Ebelt has collaborated with scholars based in United States, Egypt and Italy. Frequent co-authors include Edwin R. Manuel, Monica Marzagalli, Carla L. Van Den Berg, M. A. Cantrell, Travis H. Stracker, Blerta Xhemalçe, Kyle M. Miller, Kevin N. Dalby, Ramakrishna Edupuganti and Tamer S. Kaoud. Their work appears in journals such as Cancers, Oncotarget, Nature Communications, Cancer Research and Cellular and Molecular Bioengineering.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.